What is Propanc Biopharma, Inc. Common Stock's Market Cap?

Propanc Biopharma, Inc. Common Stock's Market Cap is $1.8M, based on as-reported figures from SEC (XBRL) filings.

What is Propanc Biopharma, Inc. Common Stock's Enterprise Value?

Propanc Biopharma, Inc. Common Stock's Enterprise Value is $940.7K, based on as-reported figures from SEC (XBRL) filings.

What is Propanc Biopharma, Inc. Common Stock's EV / EBITDA?

Propanc Biopharma, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Propanc Biopharma, Inc. Common Stock's Revenue (TTM)?

Propanc Biopharma, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.

What is Propanc Biopharma, Inc. Common Stock's Net Income (TTM)?

Propanc Biopharma, Inc. Common Stock's Net Income (TTM) is -$19.8M, based on as-reported figures from SEC (XBRL) filings.

What is Propanc Biopharma, Inc. Common Stock's EBITDA?

Propanc Biopharma, Inc. Common Stock's EBITDA is -$18.2M, based on as-reported figures from SEC (XBRL) filings.

What is Propanc Biopharma, Inc. Common Stock's Diluted EPS (TTM)?

Propanc Biopharma, Inc. Common Stock's Diluted EPS (TTM) is -3.13, based on as-reported figures from SEC (XBRL) filings.

What is Propanc Biopharma, Inc. Common Stock's Net Debt?

Propanc Biopharma, Inc. Common Stock's Net Debt is -$832.0K, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / PHARMACEUTICAL PREPARATIONS

Propanc Biopharma, Inc. Common Stock

XNAS · usd

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG002086411

0.28▲ 0.01 (2.19%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E: —
Price / Sales: —
EV / Revenue: —
EV / EBITDA

Financial Highlights

Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin: —
Net Debt

Trading Information

Previous Close: 0.27
Day's Range: 0.25 – 0.28
52-Week Range: 0.06 – 6.79
Volume: 248.9K
Avg Volume: 330.9K

Share Statistics

Shares Outstanding
Employees: 2
Exchange: XNAS
Listed: 2012-06-15

Share count as of September 23, 2026

Propanc Biopharma, Inc. Common Stock (PPCB) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Propanc Biopharma, Inc. Common Stock (PPCB)

What is Propanc Biopharma, Inc. Common Stock's Market Cap?: Propanc Biopharma, Inc. Common Stock's Market Cap is $1.8M, based on as-reported figures from SEC (XBRL) filings.
What is Propanc Biopharma, Inc. Common Stock's Enterprise Value?: Propanc Biopharma, Inc. Common Stock's Enterprise Value is $940.7K, based on as-reported figures from SEC (XBRL) filings.
What is Propanc Biopharma, Inc. Common Stock's EV / EBITDA?: Propanc Biopharma, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Propanc Biopharma, Inc. Common Stock's Revenue (TTM)?: Propanc Biopharma, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Propanc Biopharma, Inc. Common Stock's Net Income (TTM)?: Propanc Biopharma, Inc. Common Stock's Net Income (TTM) is -$19.8M, based on as-reported figures from SEC (XBRL) filings.
What is Propanc Biopharma, Inc. Common Stock's EBITDA?: Propanc Biopharma, Inc. Common Stock's EBITDA is -$18.2M, based on as-reported figures from SEC (XBRL) filings.
What is Propanc Biopharma, Inc. Common Stock's Diluted EPS (TTM)?: Propanc Biopharma, Inc. Common Stock's Diluted EPS (TTM) is -3.13, based on as-reported figures from SEC (XBRL) filings.
What is Propanc Biopharma, Inc. Common Stock's Net Debt?: Propanc Biopharma, Inc. Common Stock's Net Debt is -$832.0K, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · PPCBAs-filed SEC (XBRL) data